Regulation of epidermal growth factor receptor metabolism in gingival fibroblasts by phenytoin in vitro.
Normal human gingival fibroblasts derived from five children between 8 and 12 yr of age were cultured under serum-free conditions in the presence of epidermal growth factor (EGF) either alone or in combination with 5,5-diphenylhydantoin (phenytoin; PHT). DNA-synthesis, binding of EGF to its cell-surface receptor and internalisation of EGF-receptor-ligand complexes were studied. In normal gingival fibroblasts treated solely with EGF for 48 h, DNA synthesis increased significantly, as in cells treated solely with PHT. When EGF binding data was calculated according to Scatchard, it was found that the number of EGF receptors in fibroblasts increased significantly after PHT treatment. The number of EGF-receptors in untreated gingival fibroblasts varied from 147,000 to 170,000 receptors per cell whereas in PHT-treated fibroblasts the range was from 181,000 to 280,000. The study indicates that PHT regulates EGF-receptor metabolism in human gingival fibroblasts by increasing the number of cell-surface EGF-receptors which may contribute to the alteration of gingival connective tissue observed in patients undergoing PHT medication.
Modéer
T
T
Department of Pedodontics, Karolinska Institute, Huddinge, Sweden.
Andersson
G
G
D002648:Child; D004247:DNA / Q000096:biosynthesis; D004815:Epidermal Growth Factor / Q000378:metabolism*; D066246:ErbB Receptors / Q000187:drug effects* / Q000378:metabolism; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism*; D005881:Gingiva / Q000166:cytology* / Q000187:drug effects; D006801:Humans; D010672:Phenytoin / Q000494:pharmacology*; D011485:Protein Binding
D010672:Phenytoin; D004815:Epidermal Growth Factor; D004247:DNA; D066246:ErbB Receptors